Michel Accad. (2017). Moving Mountains: A Socratic Challenge to the Theory and Practice of Population Medicine. Huntsville, TX: Green Publishing House. ISBN 978-1-63432-030-6. A Dichotomization of Health? by Wyer, Peter C.









Michel Accad. (2017). Moving Mountains: A Socratic Challenge 
to the Theory and Practice of Population Medicine. Huntsville, 
TX: Green Publishing House. ISBN 978-1-63432-030-6. A 
Dichotomization of Health? 
 
Peter C Wyer MD  
 
Associate Professor of Medicine, Columbia University Medical Center, New York, NY, USA 
 
Keywords 
Clinical outcomes, dichotomization of health, disease, epidemiology, evidence-based medicine, health, hypertension, 
person-centered healthcare, personhood, population health, population medicine, public health 
 
Correspondence address 
Dr. Peter Wyer, Department of Emergency Medicine, Columbia University, 622 W  168th  Street, New York, NY 10032, 
USA. E-mail: pw91@cumc.columbia.edu 
 





Within today’s healthcare system, conflicting priorities and 
the varying perspectives of patients and providers are the 
leading drivers of complexity. The health of populations 
and the care of individual patients define two such 
perspectives and are potentially in conflict. Because each 
of these perspectives is characteristically dominant within 
particular healthcare stakeholder constituencies, they may 
be equated with the specific roles played by those parties. 
“Population health” may seem to be the property of 
insurers and government regulators, whose principal 
concerns are costs and the allocation of healthcare 
resources. Reciprocally, individualized patient care 
constitutes a domain that practitioners are prone to claim as 
their own. However, a simple equation of perspective with 
role breaks down once it is recognized that populations are 
comprised of individual people whose health interests are 
inevitably bound up with those of their fellow citizens and 
of the communities of which they are part. For example, 
when a local or regional government abdicates 
responsibility for water safety, children in the community 
may come down with serious and irreversible 
manifestations of lead toxicity and emphatically 
“individual” health problems may result [1]. Reciprocally, 
when parents within a community, whether based upon 
false information and ignorance or on their interpretations 
of religious dogma, decline to allow their children to 
receive routine childhood immunizations, herd immunity 
may break down and epidemics of infectious diseases such 
as measles, hemophilus influenza type B or even polio may 
emerge [2]. Furthermore, the perspectives of individual 
protagonists within the healthcare enterprise cannot be 
predicted with accuracy. For example, a leading figure in 
health economics today, Michael Porter, is a champion of 
the priority of individual patient valuation of health 
outcomes as the bed rock foundation of health economic 
theory and policy [3].  
Michel Accad, an American internist and cardiologist 
in private practice in California, makes his perspective on 
the healthcare system crystal clear in the course of his 
book “Moving Mountains: A Socratic Challenge to the 
Theory and Practice of Population Medicine”  (hereafter 
“Moving Mountains”), closing the volume with the 
thought:  “... we can hope for the return of a more natural 
medicine, caring for patients one individual at a time” [2]. 
Accad has framed his impassioned defense of the domain 
of individualized patient care as a polemic against the 
concept of population health. The body of the book is set 
as a fantasied Socratic debate in which Accad plays both 
parts, that of the ancient Greek sage and also that of 
Geoffrey Rose, a British epidemiologist who died in 1993 
and who is widely credited as the originator of the 
theoretical basis of the population health construct. 
Although it seems unlikely that the historical Socrates had 
a personal opinion on the issues of population health or of 
Rose’s contributions, the Socrates of “Moving Mountains” 
is advantaged by knowledge of writings that appeared after 
Rose’s demise and also seems to have well defined 
contemporary political views. A clinical focus, the 
definition and management of hypertension, pervades the 
volume and makes the arguments particularly salient 
today. Rose was a student of Sir George Pickering, whose 
treatise on blood pressure [5] embodied many of the 
principles that were subsequently generalized by his 
student as the premises of population health. 
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The imaginary dialogue with Rose in “Moving 
Mountains” is sandwiched between an Introduction and an 
Epilogue, in which Accad avowedly voices his own views. 
Along the way, the reader finds some perceptive insights, 
particularly the observation that evidence-based medicine 
(EBM), as an ideology, can be seen as an attempt to 
subjugate the care of individual patients to population-
based findings [6]. Ultimately, Accad paints a uniformly 
dour picture of the population health movement and 
appears to conflate it with most of the toxicities that he 
perceives within the current climate of healthcare. He does 
not, however, identify or elaborate the specific ways that 
current concepts of population health and related programs 
impinge upon or impede the ability of a practitioner to care 
for her or his patients in a satisfying way. This is a 
substantial weakness of “Moving Mountains”. As a result, 
much of the argument is unfocused and, at times, flailing. 
Furthermore, Accad’s representation of Rose’s views as 
presented in the latter’s main writings [7,8] is distorted. 
What makes Accad’s book worthy of comment is its 
pertinence to current issues on the healthcare scene, 
particularly recent developments in the field of 
hypertension. It also highlights the need for precision in 
distinguishing between specific dimensions of scientific 
inquiry related to healthcare and the political interests with 
which they may transiently seem to cohere. The current 
review continues by successively addressing Rose’s view 
of the interplay between population health and individual 
patient care, with application to the hypertension issue and, 




Geoffrey Rose and Population 
Health 
 
Accad’s fantasy dialogue between a prestigious British 
epidemiologist and an ancient sage constitutes a novel 
vehicle and, at times, makes for entertaining reading. It 
renders the volume easily approachable by readers not 
otherwise familiar with such content. The book can be 
recommended to interested readers as a quick introduction 
to the issues surrounding the topic of population health that 
are potentially troublesome to professionals whose training 
and orientation has been devoted to the care of individual 
patients. Readers desiring more than a cursory introduction 
to those issues will need to appreciate that Accad’s 
representation of Rose does not ultimately do justice to the 
latter’s ideas. Specifically, what Accad denounces at the 
end of his introduction as a “confused hodge-podge of 
propositions that are untenable on clinical, 
epidemiological, social and ethical grounds” [4] is 
probably more accurately seen as Rose’s attempt to 
elucidate the complexity underlying the issues of 
population versus individual health and the interplay of 
healthcare options, interventions and tradeoffs between 
individual and population health outcomes that need to be 
considered in the context of health policy development. To 
clarify the distinction between the Rose of his published 
writings and Rose as represented in “Moving Mountains”, 
I will outline the former in some detail. 
Although Rose’s “Strategy for Preventive Medicine” 
[8] is his seminal work, the publication that perhaps most 
clearly presents the underlying kernel insight appeared in 
the International Journal of Epidemiology in 1985 [7]. The 
essential idea is straightforward.  Standard approaches to 
the assessment of risk within a population involve 
statistical techniques such as logistic regression that are an 
accurate way of identifying factors within the population 
that increase or decrease the relative risk of acquiring or of 
suffering an outcome of a disease among individuals. 
However, such techniques fall short when it comes to 
identifying characteristics that are shared by all individuals 
within the population. The latter requires comparisons 
across societies, cultures or populations. The second part 
of Rose’s insight is that the identification of risk factors 
that pertain to a population as a whole opens the door to 
consideration of classes of intervention that transcend the 
domain of the individual patient and may in fact not 
require that the beneficiaries be identified as “patients” at 
all, thereby side-stepping the de-personalizing aspects of 
much of healthcare in modern Society. Among such factors 
and potential interventions is a class of determinants that 
are not ordinarily considered to be “medical” and that lie 
outside of the domain of clinical practice to address. These 
are commonly called the “social determinants of heatlh” 
[9]. Rose’s concept, however, applies no matter whether 
the determinants in question are properly “medical” or 
simply “social.” The characteristics in question may or 
may not conform to a normal distribution curve within a 
target population. In fact, the essential concept does not 
require that the distributions be normal or even uni-modal. 
Rose’s conjecture, based upon his mentor Pickering’s 
insight regarding hypertension [5], is that population-based 
interventions might shift the distribution of such 
characteristics and the burden of consequent unwelcome 
health outcomes in a favorable direction. Hence the image 
of “Moving Mountains” employed by Accad as the title of 
his book [4].  
Throughout his book [8], Rose appears intent on 
avoiding oversimplifying the interplay between the 
individual patient versus the population-based approaches. 
Rather, he sees advantages and disadvantages of both 
levels of intervention. For example,  the individual patient, 
or “dichotomized” approach [8] selects individuals who, 
by virtue of their personal characteristics or severity of 
presentation, are at higher risk of adverse health outcomes, 
defines them as patients and recommends treatment. Much 
of the time this means therapy with pharmacological 
agents. This approach seeks a relatively high likelihood of 
individual benefit from such treatment. It also renders it 
relatively easy to monitor healthcare facilities and 
individual practitioners for compliance with 
recommendations and, reciprocally, easier for the latter to 
demonstrate such compliance. The principal disadvantage 
of the individual patient approach is that individuals with 
lower severity and lower risk of the unwanted outcomes 
are much less likely to benefit personally even though they 
are at the same risk of adverse treatment effects [8]. They 
also have to assume the role of “patients” with the 
consequent threats to personhood. At the same time, 
collectively, these lower risk individuals far outnumber 
those in the higher risk group. Consequently, it is people 





who are at lower personal risk who ultimately contribute 
the majority of unwanted outcomes within the population 
[7,8]. Hence, maximizing the likelihood of benefit for the 
individual patient works against the interests of population 
health. Furthermore, simply lowering the thresholds for 
recommended treatment results in converting many more 
individuals into “patients” and exposes them to adverse 
effects of treatment when in fact their absolute risks of 
such outcomes are very small. To the extent that a 
population-based intervention were available that could 
uniformly and collectively modify the relevant risk factor, 
then the adverse effects of treatment, the problem of “false 
positive” screening results and the unnecessary labeling of 
individuals as “patients” could all be avoided. 
Rose, of course, is not unique in having identified the 
relative absence of individual incentive that accompanies 
adherence to recommendations that may be extremely 
beneficial on a population-based level. On 25 October 
2017, The Times of London carried the following from a 
Letter to the Editor: 
 
“… I am one of the 1.4 million people who should be on 
a statin, but isn’t (‘Doctors give statins to only one fifth 
of patients who qualify’, News, Oct 24). When the 
National Institute for Health and Care Excellence 
recommended that I take the drug in 2014, I went to the 
NICE website to work out how much benefit I would 
gain. A year of statin treatment would prolong my life 
by 18 hours. Even before subtracting the time I would 
lose collecting repeat prescriptions, I decided it wasn’t 
worth  the bother” [8].  
 
However, the population-based approach has its own 
disadvantages, as Rose elaborates in the later chapters of 
his treatise [8]. Firstly, there may not be a viable point of 
intervention capable of affecting the population as a whole 
in the desired fashion. Secondly, even if such exists, it may 
require coercive methods to successfully implement. Rose 
is clear in his rejection of the latter and advocates an 
approach in which individual choice is preserved. In other 
words, he seems to reject a “nanny state” approach to 
public health interventions. It is not clear where he would 
draw the line or how he would have responded to 
approaches such as those implemented in New York City a 
few years ago [11]. However, Rose recognized that both 
individual-based and population-based practice needed to 
co-exist in harmony. In Chapter 2 of his book he states: 
  
“Disease truly forms a continuum of severity, but its 
management requires a system of unambiguous labels. 
The big mistake has been, not the use of dichotomous 
diagnostics, but to consider that process as being a 
description of the natural order rather than merely an 
operational convenience. Management policy requires 
‘yes/no’ decisions such as investigate or not 
investigate, admit or send home, treat or not treat … 
To improve the nation’s health statistics for 
consultations, hospital admissions, and mortality is 
indeed an important measure of preventive success, 
but it is not sufficient for it fails to consider that much 
of the population’s burden of ill health derives from a 
mass of less obvious troubles which doctors do not 
see. For example, in our studies of angina we found 
that only about a quarter of all the sufferers had ever 
been diagnosed. There is a vast submerged burden of 
ill health” [8]. 
 
Returning to the Rose of “Moving Mountains” [4], 
Accad lends a semblance of authenticity of his 
representation by interspersing the text with cited direct 
quotations from Rose’s writings. However, the excerpts are 
selected and Rose’s actual views are distorted. Accad 
seems bent on the portrayal of the population health 
concept as adversarial to the care of individual patients and 
chooses to interpret Rose’s articulate acknowledgement of 
the complexity of the issues as evidence of “a confused 
hodge-podge of propositions”, ignoring the actual thread of 
Rose’s argument. Indeed, a glaring example of Accad’s 
distortion of Rose occurs in connection with the principle 
of informed individual choice and the highly related 
construct of shared decision-making [12]. In his Chapter 5, 
Accad (as both Socrates and Rose) portrays Rose as a 
traditional, paternalistic, prescriber of what is “good for” 
the individual patient and as an adversary of shared 
decision-making [4]. However, in Chapter 8 of his treatise, 
Rose himself pronounces: 
 
“The treatment is offered, and individuals can then 
decide for themselves whether or not they wish to take 
it. Nothing is imposed and no one is compelled. This 
applies whenever the potential recipients are free to 
accept or reject the advice, whether it be on fluoridated 
toothpaste, diet, or smoking. This freedom of choice is 
only effective if those concerned have access to all the 
relevant information and are able to understand it. In 
practice, access to relevant information may be difficult 
or impossible to obtain because those who control its 
supply may not wish or be able to share it fully or to 
present it in a neutral, value-free way. Physicians and 
their teams present information so as to favour what they 
see as the right choice, and the news media present it so 
as to favour their editorial policy or to make a good 
story” [8]. 
 
It would seem that Accad’s distortion of Rose is not the 
arbitrary result of hasty reading or of academic 
inexperience, but rather a systematic attempt to portray 
Rose as the mother of evil behind an ongoing quest to 
“advance population medicine as a replacement for 
traditional patient care” as voiced by Accad  on page 2 of 
his Introduction [4]. 
 
  
The Case of Hypertension 
 
The issues raised by Rose and more indirectly by Accad’s 
critical dialogue [4], are rendered particularly salient by 
recent developments in the field of hypertension definition 
and management. Much of Rose’s theory of population 
health was founded on a proposition introduced by his 
teacher, Sir George Pickering, that blood pressure values 
are continuously distributed across the population [5]. If 
this were the case, then the establishment of a dichotomous 
cut-off above which pressures would be considered to be 
“abnormal” and subject to modification for purposes of 
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diminishing cardiovascular risk, would be arbitrary and 
necessarily a matter of “operational convenience”, rather 
than a physiologically defined value [8]. The lower the 
threshold value, the larger percentage of the population is 
arbitrarily defined as “diseased” and the lower the 
efficiency of treatment for the individual. On the other 
hand, if interventions could be identified that could be 
applied to the entire population, efficiency would no longer 
be defined on an individual patient basis [8].   
Recent developments within the US hypertension 
guideline community bear directly on these issues. Over 
the last two decades, the recommended treatment threshold 
level for blood pressure elevation advanced by the US 
Joint National Committee on Hypertension and by the 
American Heart Association (AHA) in conjunction with 
the American College of Cardiology (ACC) has been 
gradually decreasing. The latest update of the AHA/ACC 
guidelines, released in 2017, recommends a lowering of 
the threshold for defining treatable blood pressure 
elevation from 140 mm Hg  to 130 mm Hg  systolic [13]. 
As a result, relative to the previous recommendations, an 
additional 13% of US adults, or a total of just over 45%, 
will be defined as hypertensives [11]. However, only an 
additional 2% of the population will be recommended to 
consider drug therapy based upon increased risk factors for 
cardiovascular disease. This likely reflects concern for 
increased side effects of treatment which can include 
hypotension and syncope. Such effects were observed in 
the SPRINT trial upon which the new recommendations 
are largely based [14].   
The magnitude of potential benefit for individuals 
whose blood pressures lie in the lower range of the 
treatment eligible group is small. The SPRINT trial 
enrolled non-diabetic participants whose cardiovascular 
risk was calculated to be high [14]. The magnitude of 
benefit for those receiving active treatment was about half 
of a percent lower likelihood of an important 
cardiovascular outcome per year. The benefit for 
individuals lacking such risk factors would be only 3% 
over a 10 year period [15,16]. This means that, on average, 
33 low risk people would have to be treated, 
pharmacologically or otherwise, for 10 years for a single 
person to avoid an event. The new hypertension 
recommendations also have important implications for 
individuals with higher pressures who are already under 
treatment. Since many of them, even with treatment, have 
pressures outside the new threshold range, they will need 
more intensive therapy and more drugs and will risk more 
serious adverse effects of treatment [15]. It would seem 
that the consequences of trends in recommendations for 
defining and managing hypertension well illustrate the 
principles elaborated by Rose [8]. That is, the lower the 
threshold for defining individual “disease”, the greater the 
shift from individual to population level benefit [15,16]. 
When the threshold is lowered, more cardiovascular events 
are avoided at the expense of greater numbers of 
individuals being defined as “diseased” and being treated 
with minimal individual health benefit and despite the 
same risk of adverse events from treatment. As an 
advocate of population-based interventions, it would seem 
that Rose might well be viewed as a champion of person-
centered healthcare. That is, for purposes of maximizing 
health outcomes on a population level, Rose favored 
population level interventions, minimizing the need to 
define individual persons as “diseased patients”.    
Although Accad quibbles with some of Pickering’s 
original assumptions [5] based on a paper published in 
1983 [17], subsequent clinical research seems to have 
consistently born out Rose’s projections. To be sure, an 
effective approach to treatment of hypertension, as a 
population level “disease”, rather than as an individual 
ailment, is yet to be identified. However, Rose was not in 
his writings claiming to have found magic bullets or 
perfect solutions. Rather, he seems to have been attempting 
to characterize the complexity of health problems such as 
hypertension and in so doing to clearly differentiate 
between disease as we conventionally understand it on an 
individual level and potentially treatable characteristics on 
a population level. From thirty years of clinical experience 
as an emergency physician, this reviewer can attest that 
confusion regarding hypertension as a primary clinical 
entity versus as a predictor of clinical outcomes has been 
and remains rampant in the emergency room. Specifically, 
the practice of acutely lowering elevated blood pressures 
(which in the ER commonly reflect a normal physiological 
response to the stress of being in that environment), 
although consistently discouraged in published guidelines, 
has proved very difficult to curtail. Indeed, for over 20 
years the practice has been known to cause harm [18,19]. 
Its persistence appears to reflect health professionals’ 
conceptual difficulty in grasping Rose’s principal point 
within an acute care setting. 
 
 
Some Additional Considerations and 
Conclusion 
 
“Moving Mountains” is written for a middle level 
readership and, despite its limitations, provides a very 
approachable vehicle for readers such as clinicians and 
interested health consumers to gain an initial appreciation 
of the nature of the issues.  However, readers should 
consult original sources if they wish to gain a fully 
informed understanding of the relevant perspectives. 
Readers should be able to detect for themselves the 
somewhat idiosyncratic, if impassioned, nature of Accad’s 
views on matters of ethics and social justice. For example, 
in the epilogue, he implies that the American College of 
Physicians Ethics, Professionalism and Human Rights 
Committee is a mere tool of health policy makers and the 
insurance industry [4]. Accad cites the following as 
evidence thereof: 
 
“Resource allocation decisions are most appropriately 
made at the policy level rather than entirely in the 
context of an individual patient–physician encounter. 
Ethical allocation policy is best achieved when all 
affected parties discuss what resources exist, to what 
extent they are limited, what costs attach to various 
benefits, and how to equitably balance all these factors” 
[20].  
 
Considering that new drugs are being introduced into 
the marketplace  at a price of half a million US dollars  per 





dose [21],  Accad’s implied suggestion that the insurance 
industry should be excluded from deliberations about 
allocations of healthcare resources seems out of touch. 
Accad’s responses to the non-medical side of Rose’s 
original thesis verge on flailing. He apparently regards 
recognition of social, economic and environmental factors 
as health co-determinants and the importance of addressing 
disparities in the quality of delivered healthcare to be 
tantamount to an ultra-left wing political agenda. In the 
body of the dialogue Accad, as Socrates, all but brands 
Accad, as Rose, a communist, referring to his treatise as 
“The Little Rose Book” [4]. In the Epilogue, he equates the 
principles of population health to a utopian, “egalitarian” 
world view. Quite apart from matters of personal political 
perspective, it seems unclear why eliminating disparities in 
health and living conditions and extending healthcare 
access to the entire population would not be favored by 
health professionals as a natural consequence of their role 
in Society. This aspect of Accad’s perspective is not 
explained in his book.   
For reasons that are poorly substantiated in “Moving 
Mountains”,  Accad has settled on the population health 
construct as the principal source of evil within today’s US 
healthcare system. Of course, one might find it refreshing 
to find that something other than evidence-based medicine 
(EBM) has been placed in this role. (Published 
perspectives on the latter have suggested that “EBM” 
might better be understood as an abbreviation for either 
“Everything Bad in Medicine” [22] or, in a reborn mode, 
as “Everything Best in Medicine” [23] ).  As previously 
noted, Accad observes that EBM, as “evidence-based 
medicine”,  insofar as it has attempted to subjugate clinical 
decision-making to findings drawn from studies on 
research populations, could be seen as a special case of 
infringement of population-based principles into the 
domain of clinical practice. Although somewhat 
metaphorical, this notion ranks as a highlight of his book 
and is appropriately referenced to the published literature 
[6]. However, ultimately, the attempt to find a single, 
convictable culprit behind the toxicities of what has 
become in the US a multi-trillion dollar per year healthcare 
enterprise, is likely destined to generate only confusion and 
consternation and to distract from the kind of concerted 
and coordinated efforts required to create a dent in the 
complexity of the problems. 
All this said, the degree of consternation among 
American private medical practitioners in recent years 
should not be under-estimated or dismissed in importance. 
Piled on demands for “documentation”, endless piles of 
forms and applications, be they electronic or paper, 
mandated electronic medical record systems that do not 
work, the constant threat of lawsuits and the defensive 
necessities to avert them, required authorizations, 
insurance denials requiring resubmitted requests, the list 
goes on and on, collectively exerting enormous pressure. 
Within this maelstrom, insurance companies and 
government regulators constitute conspicuous targets. 
Michel Accad’s perspective certainly reflects the pressures 
that practitioners in such systems are experiencing, as does 
his expressed yearning to return to an idyllic time during 
which practitioners and patients could conduct their affairs 
within a truly private practice setting. Accad is exceptional 
insofar as he has taken the time to put thoughts on paper 
that pertain to the dilemmas in which he and his colleagues 
find themselves. Readers may gain an initial, if distorted, 
picture of what the population health issue is all about and 
may appreciate something about the context which gave 
rise to the narrative. They may also hope that the author 
considers developing a more direct elaboration of the 
nature of the threats to the care of individual patients that 
he perceives and of how they relate to the various elements 
at play within today’s healthcare environment. 
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